Latest filing published 17 Aug 2015 for CymaBay Therapeutics, Inc., €75k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kurt von Emster: trading record in brief
Kurt von Emster is a declared insider of CymaBay Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 3 filings, for trades running from 20 July 2015 to 14 August 2015.
Purchases make up the whole of the open-market record (3 purchases, €4.4M). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €142k.
The newest entry dates from 17 August 2015: an open-market purchase of €75k, in CymaBay Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kurt von Emster
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 31,359 shares@ US$2.68Common StockSEC:0001179110-15-012232:0Canonical exit: 11 Nov 2015 (T+90)
- 58,641 shares@ US$2.70Common stockSEC:0001179110-15-012232:1Canonical exit: 12 Nov 2015 (T+90)
- 1,600,000 shares@ US$2.81Common StockSEC:0001179110-15-011396:0Canonical exit: 18 Oct 2015 (T+90)
3 of 3 declarations
